{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:40:10Z","timestamp":1759848010981},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"788","license":[{"start":{"date-parts":[[1991,6,1]],"date-time":"1991-06-01T00:00:00Z","timestamp":675734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1991,6,1]]},"DOI":"10.1136\/pgmj.67.788.506","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:01:03Z","timestamp":1230584463000},"page":"506-508","source":"Crossref","is-referenced-by-count":6,"title":["Management of carcinoid syndrome"],"prefix":"10.1093","volume":"67","author":[{"given":"A","family":"Saini","sequence":"first","affiliation":[{"name":"Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital , Du Cane Road, London W12 0NN, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Waxman","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Royal Postgraduate Medical School, Hammersmith Hospital , Du Cane Road, London W12 0NN, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1991,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00365528708991864","article-title":"Circulating tachykinins (Substance P, neurokinin A, neuropeptide K) and the carcinoid flush","volume":"22","author":"Conlon, J.M.; Deacon, C.F.; Richter, G.; Stockmann, F.; Creutzfeldt, W.","year":"1987","unstructured":"Conlon, J.M., Deacon, C.F., Richter, G., Stockmann, F. & Creutzfeldt, W. Circulating tachykinins (Substance P, neurokinin A, neuropeptide K) and the carcinoid flush. Scand J Gastroenterol 1987, 22: 97-105.","journal-title":"Scand J Gastroenterol"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1210\/jcem-68-4-796","article-title":"The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome","volume":"68","author":"Oberg, K.; Norheim, I.; Theodorsson, E.; Ahlman, H.; Lundqvist, G.; Wide, L.","year":"1989","unstructured":"Oberg, K., Norheim, I., Theodorsson, E., Ahlman, H., Lundqvist, G. & Wide, L. The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome. J Clin Endocrinol Metab 1989, 68: 796.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref_3","article-title":"Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management","author":"Vinik, A.I.; Thompson, N.; Eckhauser, F.; Moattari, A.R.","year":"1989","unstructured":"Vinik, A.I., Thompson, N., Eckhauser, F. & Moattari, A.R. Clinical features of carcinoid syndrome and the use of somatostatin analogue in its management. Acta Oncol 1989, 28: Fasc 3.","journal-title":"Acta Oncol; 28: Fasc 3"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.1983.1.11.727","article-title":"Treatment of the carcinoid tumour and the malignant carcinoid syndrome","volume":"1","author":"Moertel, C.G.","year":"1983","unstructured":"Moertel, C.G. Treatment of the carcinoid tumour and the malignant carcinoid syndrome. J Clin Oncol 1983, 1: 727-740.","journal-title":"J Clin Oncol"},{"key":"ref_5","first-page":"1021","article-title":"Therapy for symptoms in the carcinoid syndrome","volume":"271","author":"Coupe, M.; Levi, S.; Ellis, M.","year":"1989","unstructured":"Coupe, M., Levi, S., Ellis, M. et al. Therapy for symptoms in the carcinoid syndrome. Q J Med 1989, 271: 1021-1036.","journal-title":"Q J Med"},{"key":"ref_6","first-page":"327","article-title":"Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome","volume":"2","author":"Moertel, C.G.; Hanley, J.A.","year":"1979","unstructured":"Moertel, C.G. & Hanley, J.A. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Clin Trials 1979, 2: 327-334.","journal-title":"Cancer Clin Trials"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/1097-0142(19871215)60:12<2891::AID-CNCR2820601207>3.0.CO;2-6","article-title":"A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors","volume":"60","author":"Bukowski, R.M.; Johnson, K.G.; Peterson, R.F.","year":"1987","unstructured":"Bukowski, R.M., Johnson, K.G., Peterson, R.F. et al. A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. Cancer 1987, 60: 2891-2895.","journal-title":"Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF02940296","article-title":"Carboplatin in the treatment of metastatic carcinoid tumors and paraganglioma - a phase II study","volume":"26","author":"Jodrell, D.I.; Smith, I.E.","year":"1990","unstructured":"Jodrell, D.I. & Smith, I.E. Carboplatin in the treatment of metastatic carcinoid tumors and paraganglioma - a phase II study. Cancer Chemotherap Pharmacol 1990, 26: 62-64.","journal-title":"Cancer Chemotherap Pharmacol"},{"key":"ref_9","first-page":"1323","article-title":"Treatment of carcinoid liver metastases by hepatic artery embolisation","volume":"fi:","author":"Allison, D.J.; Modlin, I.M.; Jenkins, W.J.","year":"1979","unstructured":"Allison, D.J., Modlin, I.M. & Jenkins, W.J. Treatment of carcinoid liver metastases by hepatic artery embolisation. Lancet 1979, fi: 1323-1325.","journal-title":"Lancet"},{"issue":"70","key":"ref_10","first-page":"1297","article-title":"Treatment of malignant carcinoid tumours with human leucocyte interferon - long term results","volume":"1986","author":"Oberg, K.; Norheim, I.; Lind, E.","unstructured":"Oberg, K., Norheim, I., Lind, E. et al. Treatment of malignant carcinoid tumours with human leucocyte interferon - long term results. Cancer Treat Rep 1986, 70: 1297-1304.","journal-title":"Cancer Treat Rep"},{"key":"ref_11","article-title":"Interferon treatment in patients with malignant carcinoids","author":"Nobin, A.; Lindblom, A.; Mansson, B.; Sundberg, M.","year":"1989","unstructured":"Nobin, A., Lindblom, A., Mansson, B. & Sundberg, M. Interferon treatment in patients with malignant carcinoids. Acta Oncol 1989, 28: Fasc 3.","journal-title":"Acta Oncol; 28: Fasc 3"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0277-5379(89)90107-7","article-title":"Treatment of malignant carcinoid tumours: a randomised controlled study of streptozotocin plus 5-Fu and human leucocyte interferon","volume":"25","author":"Oberg, K.; Norheim, I.; Alm, G.","year":"1989","unstructured":"Oberg, K., Norheim, I. & Alm, G. Treatment of malignant carcinoid tumours: a randomised controlled study of streptozotocin plus 5-Fu and human leucocyte interferon. Eur J Cancer Clin Oncol 1989, 25: 1475-1479.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"ref_13","article-title":"Recombinant alpha 2 interferon with or without hepatic artery embolisation in the treatment of midgut carcinoid tumours","author":"Hanssen, L.E.; Schrumpf, E.; Kolbenstvedt, A.N.; Tausjo, J.; Dolva, L.O.","year":"1989","unstructured":"Hanssen, L.E., Schrumpf, E., Kolbenstvedt, A.N., Tausjo, J. & Dolva, L.O. Recombinant alpha 2 interferon with or without hepatic artery embolisation in the treatment of midgut carcinoid tumours. Acta Oncol 1989, 28: Fasc 3.","journal-title":"Acta Oncol; 28: Fasc 3"},{"key":"ref_14","first-page":"633","article-title":"Treatment of the malignant carcinoid syndrome, evaluation ofa long acting somatostatin analogue","volume":"35","author":"Kvols, L.K.; Moertels, C.G.; O'Connell, M.J.; Schute, A.J.; Rudin, J.; Hahn, R.G.","year":"1986","unstructured":"Kvols, L.K., Moertels, C.G., O'Connell, M.J., Schute, A.J., Rudin, J. & Hahn, R.G. Treatment of the malignant carcinoid syndrome, evaluation ofa long acting somatostatin analogue. N Engi J Med 1986, 35: 633-636.","journal-title":"N Engi J Med"},{"issue":"313","key":"ref_15","first-page":"1229","article-title":"Carcinoid crisis: rapid reversal of life threatening hypotension with a somatostatin analogue","volume":"1985","author":"Kvols, L.K.; Martin, J.K.; Marsh, H.M.; Moertel, C.G.","unstructured":"Kvols, L.K., Martin, J.K., Marsh, H.M. & Moertel, C.G. Carcinoid crisis: rapid reversal of life threatening hypotension with a somatostatin analogue. N Engl J Med 1985, 313: 1229.","journal-title":"N Engl J Med"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/67\/788\/506\/50075505\/postgradmedj-67-506.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/67\/788\/506\/50075505\/postgradmedj-67-506.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T16:26:10Z","timestamp":1682612770000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/67\/788\/506\/7061685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,6,1]]},"references-count":15,"journal-issue":{"issue":"788","published-online":{"date-parts":[[1991,6,1]]},"published-print":{"date-parts":[[1991,6,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.67.788.506","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1991,6]]},"published":{"date-parts":[[1991,6,1]]}}}